U.S. flag

An official website of the United States government

NM_000138.5(FBN1):c.3128A>G (p.Lys1043Arg) AND Neonatal Marfan syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 1, 1997
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000017909.29

Allele description [Variation Report for NM_000138.5(FBN1):c.3128A>G (p.Lys1043Arg)]

NM_000138.5(FBN1):c.3128A>G (p.Lys1043Arg)

Gene:
FBN1:fibrillin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q21.1
Genomic location:
Preferred name:
NM_000138.5(FBN1):c.3128A>G (p.Lys1043Arg)
HGVS:
  • NC_000015.10:g.48488448T>C
  • NG_008805.2:g.162341A>G
  • NM_000138.5:c.3128A>GMANE SELECT
  • NP_000129.3:p.Lys1043Arg
  • LRG_778t1:c.3128A>G
  • LRG_778:g.162341A>G
  • NC_000015.9:g.48780645T>C
  • NM_000138.4:c.3128A>G
Protein change:
K1043R; LYS1043ARG
Links:
OMIM: 134797.0027; dbSNP: rs137854472
NCBI 1000 Genomes Browser:
rs137854472
Molecular consequence:
  • NM_000138.5:c.3128A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Neonatal Marfan syndrome
Identifiers:
MONDO: MONDO:0017309; MedGen: C4016054

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000038188OMIM
no assertion criteria provided
Pathogenic
(Jan 1, 1997)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Three novel fibrillin mutations in exons 25 and 27: classic versus neonatal Marfan syndrome.

Wang M, Wang JY, Cisler J, Imaizumi K, Burton BK, Jones MC, Lamberti JJ, Godfrey M.

Hum Mutat. 1997;9(4):359-62. No abstract available.

PubMed [citation]
PMID:
9101298

Details of each submission

From OMIM, SCV000038188.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Wang et al. (1997) described 3 FBN1 mutations. Two of them were in patients with the neonatal form of Marfan syndrome (MFS; 154700); the third was in a patient with classic Marfan syndrome. All 3 occurred in the same region that had been found to harbor neonatal Marfan syndrome mutations. The first patient had striking skeletal features of Marfan syndrome, including soft, loose skin, crumpled ears, and joint contractures at birth. Eye and cardiac examinations were normal. At 7 months of age, he developed an aggressive scoliosis; however, his contractures were no longer evident. Hypotonia and marked mitral valve prolapse (which had not been evident at birth) were noted. At 14 months of age, an extensive mitral valve repair was performed. Postoperative complications necessitated replacement with a St. Jude mechanical prosthesis 3 weeks later and a porcine heterograft 2 months after the initial valve repair. At 20 months of age, he underwent plication of the right hemidiaphragm and resection of the bulbous cysts of the left lung. The patient died suddenly at 2 years of age. Diffuse changes of the Marfan syndrome were found in the vessels and emphysematous changes in the lungs at autopsy were noted. Amplified genomic DNA from the patient using intron primers to exon 25 showed heteroduplex formation when run on mutation detection enhancement (MDE) gels. Sequence analysis showed an A-to-G transition at position 3128 that caused a lysine-to-arginine substitution at amino acid position 1043 (K1043R) in 1 allele.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024